The Technical Analyst
Select Language :
Aytu BioScience Inc [AYTU]

Exchange: NASDAQ Sector: Healthcare Industry: Drug Manufacturers—Specialty & Generic

Aytu BioScience Inc Price, Forecast, Insider, Ratings, Fundamentals & Signals

Aytu BioScience Inc is listed at the  Exchange

-1.30% $3.04

America/New_York / 28 mar 2024 @ 16:00


Aytu BioScience Inc: Main Fundamentals PE comparison

FUNDAMENTALS
MarketCap: 16.93 mill
EPS: -4.01
P/E: -0.760
Earnings Date: May 09, 2024
SharesOutstanding: 5.57 mill
Avg Daily Volume: 0.0204 mill
RATING 2024-03-28
B+
Neutral
RATINGS
Rating CashFlow: Buy
Return On Equity: Neutral
Return On Asset: Buy
DE: Buy
P/E: Strong Sell
Price To Book: Neutral
QUARTER GROWTHS
3/224/221/232/233/234/23
Revenue
Gr.Profit
Ebit
Asset
Debt
PE RATIO: COMPANY / SECTOR
0.00x
Company: PE -0.760 | sector: PE -3.05
PE RATIO: COMPANY / INDUSTRY
-0.02x
Company: PE -0.760 | industry: PE 47.78
DISCOUNTED CASH FLOW VALUE
N/A
N/A
Expected Trading Range (DAY)

$ 2.92 - 3.26

( +/- 5.40%)
ATR Model: 14 days

Insider Trading

Date Person Action Amount type
2023-12-31 Pyszczymuka Greg Buy 209 Common Shares
2023-12-31 Pyszczymuka Greg Sell 209 Restricted Stock Units
2023-09-30 Pyszczymuka Greg Buy 208 Common Shares
2023-09-30 Pyszczymuka Greg Sell 208 Restricted Stock Units
2023-08-16 Jain Abhinav Buy 6 500 Common Shares
INSIDER POWER
30.72
Last 94 transactions
Buy: 33 552 577 | Sell: 39 056 260

Forecast: 16:00 - $3.04

Live Trading Signals (every 1 min)

Forecast 1: 16:00 - $3.04
Forecast 2: 16:00 - $3.04
Forecast 3: 16:00 - $3.04
SCORE
10.00
Buy
Score Algorithm Version: 1.2C
Last version updated: Fri April 15th, 2022
Indicator Signals
RSI 21
SMA
Trend
Trend 2
Trend 3
MACD
Volume Signals
Price $3.04 (-1.30% )
Volume 0.0152 mill
Avg. Vol. 0.0204 mill
% of Avg. Vol 74.26 %
Signal 1:
Signal 2:

Today

Intraday chart data with high, low, open and close for Aytu BioScience Inc

Last 12 Months

Last 12 months chart data with high, low, open and close for Aytu BioScience Inc

RSI

Last 10 Buy & Sell Signals For AYTU

0 Signals | Accuracy: 0.00% | Accuracy Buy: 0.00% | Accuracy Sell: 0.00%

Avg return buy: 0.00 % | Avg return sell: 0.00 %

$1 invested is now $1.00 or 0.00% since Coming Soon

Date Signal @ Closed %
Profile picture for
            Aytu BioScience Inc

AYTU

Aytu Biopharma, Inc., a specialty pharmaceutical company, focuses on developing and commercializing novel therapeutics and consumer healthcare products the United States and internationally. The company offers Adzenys XR-ODT for the treatment of attention deficit hyperactivity disorder (ADHD) in patients from 6 years and older; Cotempla XR-ODT for the treatment of ADHD in patients from 6 to 17 years old; and Adzenys ER, an oral suspension for the treatment of ADHD in patients from 6 years and older. It also provides Karbinal ER, a carbinoxamine oral suspension for the treatment of seasonal and perennial allergies; Poly-Vi-Flor and Tri-Vi-Flor prescription supplements for infants and children for the treatment of fluoride deficiency; Tuzistra XR, a prescription antitussive consisting of codeine polistirex and chlorpheniramine polistirex in an oral suspension; and ZolpiMist, an oral spray for the treatment of insomnia. The company was formerly known as Aytu BioScience, Inc. and changed its name to Aytu Biopharma, Inc. in March 2021. Aytu Biopharma, Inc. was incorporated in 2015 and is headquartered in Englewood, Colorado.

Last 10 Buy Signals

Date Signal @
NEXOUSDMar 29 - 08:531.331
BCHUSDMar 29 - 08:54$623.70
ROUTEUSDMar 29 - 08:504.37
OSMOUSDMar 29 - 08:451.380
BELUSDMar 29 - 08:440.982
DPIUSDMar 29 - 08:44$145.76
TIAUSDMar 29 - 08:3815.02
ETHUPUSDMar 29 - 08:3834.55
MPLUSDMar 29 - 08:3422.12
DCRUSDMar 29 - 08:30$28.20

Latest Press Releases

Latest News

Disclaimer:

"JimStromberg.com" is a research service that provides financial data and technical analysis of publicly traded stocks. All users should speak with their financial advisor before buying or selling any securities. Users should not base their investment decision upon "JimStromberg.com". By using the site you agree and are held liable for your own investment decisions and agree to Terms of Use and Privacy Policy. Please read the full disclaimer here.